Shilong Ning

607 total citations
18 papers, 478 citations indexed

About

Shilong Ning is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Shilong Ning has authored 18 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Pharmacology. Recurrent topics in Shilong Ning's work include MicroRNA in disease regulation (7 papers), Pharmacological Effects of Natural Compounds (5 papers) and Ginseng Biological Effects and Applications (3 papers). Shilong Ning is often cited by papers focused on MicroRNA in disease regulation (7 papers), Pharmacological Effects of Natural Compounds (5 papers) and Ginseng Biological Effects and Applications (3 papers). Shilong Ning collaborates with scholars based in China, South Korea and Hong Kong. Shilong Ning's co-authors include Xiao Ma, Fei Jiang, Juan Mu, Zhong Li, Lu Si, Yuan Li, Xingxing Wang, Yuan Li, Xingxing Wang and Chunyan Hu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Agricultural and Food Chemistry.

In The Last Decade

Shilong Ning

16 papers receiving 475 citations

Peers

Shilong Ning
Comparison fields: 5 of 60
  • Molecular Biology 346
  • Cancer Research 147
  • Pharmacology 85
  • Oncology 81
  • Immunology 56
Replace Ser Yue Loo with:
Ser Yue Loo Singapore
Kequn Chai China
Ming‐Tsung Lai Taiwan
Ji Young Sul South Korea
Julie A. Arlotti United States
Mianhua Wu China
Su‐Yu Chien Taiwan
Jeong‐Geon Mun South Korea
Nan Yao China
Ying Zan China
Ser Yue Loo Singapore View profile →
Citations per field, relative to Shilong Ning
Shilong Ning · 1×
Citations per year, relative to Shilong Ning
Shilong Ning · 1×

Countries citing papers authored by Shilong Ning

Since Specialization
Citations

This map shows the geographic impact of Shilong Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilong Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilong Ning more than expected).

Fields of papers citing papers by Shilong Ning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilong Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilong Ning. The network helps show where Shilong Ning may publish in the future.

Co-authorship network of co-authors of Shilong Ning

This figure shows the co-authorship network connecting the top 25 collaborators of Shilong Ning. A scholar is included among the top collaborators of Shilong Ning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilong Ning. Shilong Ning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
# Work Indexed citations
1 0
2 0
3 1
4 2
5 18
6 8
7 13
8 9
9 69
10 40
11 13
12 66
13 12
14 16
15 71
16 24
17 66
18 50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026